LATECOERE (LAT.PA)

FR001400JY13 - Common Stock

0.0096  +0 (+2.13%)

Fundamental Rating

1

Overall LAT gets a fundamental rating of 1 out of 10. We evaluated LAT against 42 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of LAT have multiple concerns. While showing a medium growth rate, LAT is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

LAT had negative earnings in the past year.
LAT had a negative operating cash flow in the past year.
In the past 5 years LAT reported 4 times negative net income.
In the past 5 years LAT reported 4 times negative operating cash flow.

1.2 Ratios

LAT has a worse Return On Assets (-17.69%) than 92.50% of its industry peers.
Industry RankSector Rank
ROA -17.69%
ROE N/A
ROIC N/A
ROA(3y)-23.52%
ROA(5y)-14.95%
ROE(3y)-396.82%
ROE(5y)-240.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of LAT (36.63%) is comparable to the rest of the industry.
LAT's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for LAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.07%
GM growth 5Y-0.89%

0

2. Health

2.1 Basic Checks

LAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LAT has been increased compared to 1 year ago.
The number of shares outstanding for LAT has been increased compared to 5 years ago.
LAT has a worse debt/assets ratio than last year.

2.2 Solvency

LAT has an Altman-Z score of -0.39. This is a bad value and indicates that LAT is not financially healthy and even has some risk of bankruptcy.
LAT has a Altman-Z score of -0.39. This is amonst the worse of the industry: LAT underperforms 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.39
ROIC/WACCN/A
WACC4.53%

2.3 Liquidity

A Current Ratio of 0.99 indicates that LAT may have some problems paying its short term obligations.
LAT's Current ratio of 0.99 is on the low side compared to the rest of the industry. LAT is outperformed by 82.50% of its industry peers.
A Quick Ratio of 0.47 indicates that LAT may have some problems paying its short term obligations.
With a Quick ratio value of 0.47, LAT is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.47

4

3. Growth

3.1 Past

LAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.96%, which is quite impressive.
The Revenue has grown by 41.00% in the past year. This is a very strong growth!
LAT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.56% yearly.
EPS 1Y (TTM)39.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.95%
Revenue 1Y (TTM)41%
Revenue growth 3Y-13.08%
Revenue growth 5Y-6.56%
Sales Q2Q%43.01%

3.2 Future

Based on estimates for the next years, LAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.87% on average per year.
Based on estimates for the next years, LAT will show a quite strong growth in Revenue. The Revenue will grow by 18.87% on average per year.
EPS Next Y-571.14%
EPS Next 2Y-45.86%
EPS Next 3Y-22.87%
EPS Next 5YN/A
Revenue Next Year0.62%
Revenue Next 2Y24.05%
Revenue Next 3Y18.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

LAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LAT indicates a rather expensive valuation: LAT more expensive than 82.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 44.72

4.3 Compensation for Growth

A cheap valuation may be justified as LAT's earnings are expected to decrease with -22.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.86%
EPS Next 3Y-22.87%

0

5. Dividend

5.1 Amount

No dividends for LAT!.
Industry RankSector Rank
Dividend Yield N/A

LATECOERE

EPA:LAT (7/25/2024, 7:00:00 PM)

0.0096

+0 (+2.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap119.66M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.69%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 36.63%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.99
Quick Ratio 0.47
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)39.96%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-571.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)41%
Revenue growth 3Y-13.08%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y